This inventor holds 1 USPTO granted patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Stéphane Redey: Innovator in Pharmaceutical Chemistry
Introduction
Stéphane Redey is a notable inventor based in Mulhouse, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent.
Latest Patents
Stéphane Redey holds a patent for the invention titled "1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt." This invention relates to a crystalline, stoichiometrically defined, and non-hygroscopic sulfate salt of the compound, along with a process for its preparation. The patent also discusses the use of this compound in pharmaceutical compositions, particularly as neurohormonal antagonists.
Career Highlights
Stéphane Redey is associated with Actelion Pharmaceuticals Ltd, where he has been instrumental in advancing pharmaceutical research and development. His work has led to the creation of innovative formulations that enhance the efficacy of therapeutic agents.
Collaborations
Stéphane has collaborated with notable colleagues, including Bertrand Woinet and Jean-Michel Bonard, contributing to a dynamic research environment that fosters innovation.
Conclusion
Stéphane Redey's contributions to pharmaceutical chemistry through his patent demonstrate his commitment to advancing medical science. His work continues to impact the development of effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile